← Leaderboards
Timothy B Baker
University Of Wisconsin Madison
$15,407,518
Attributed
$22,587,679
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,796,863 · 15
By mechanism
P50$27,296,201 · 8
R01$13,138,637 · 4
P01$11,511,660 · 2
K05$850,365 · 1
Top collaborators
- Michael C Fiore13 shared
- James H Stein10 shared
- Linda M Collins7 shared
- Megan E Piper2 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Michael C Fiore$34,414,854
- James H Stein$15,359,061
- Robert F Lemanske$29,535,752
- Douglas E Jorenby$2,967,109
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignInnovationBaseSmoking CessationSmokerTobacco UseEffectivenessFuturePharmaceutical PreparationsSmoking Cessation InterventionRandomizedTheoriesCost EffectivenessEngineeringLaboratoriesResourcesAbstinenceEffective InterventionAffectCounselingHealthcarePharmacotherapyCessation Of LifeCost
Grant awards (72)
Longitudinal Effects of E-cigarette Use on Cardiovascular and Pulmonary Health$1,287,821
R01 · FY2025 · HL · contact PI
Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape$856,188
R01 · FY2025 · CA
Longitudinal Effects of E-cigarette Use on Cardiovascular and Pulmonary Health$1,257,395
R01 · FY2024 · HL · contact PI
Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape$876,297
R01 · FY2024 · CA
Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care$2,551,374
P01 · FY2023 · CA
Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care$2,892,696
P01 · FY2022 · CA
Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care$2,485,496
P01 · FY2021 · CA
E-Cigarette Effects ON Markers of Cardiovascular AND Pulmonary Disease Risk$456,420
R01 · FY2021 · HL
Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care$2,485,495
P01 · FY2020 · CA
Enhancing the Effectiveness of Varenicline Based Smoking Cessation Treatment$1,585,903
R01 · FY2020 · HL · contact PI
E-Cigarette Effects ON Markers of Cardiovascular AND Pulmonary Disease Risk$458,894
R01 · FY2020 · HL
Enhancing the Effectiveness of Varenicline Based Smoking Cessation Treatment$1,760,657
R01 · FY2019 · HL · contact PI
Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care$650,585
P01 · FY2019 · CA
E-Cigarette Effects ON Markers of Cardiovascular AND Pulmonary Disease Risk$458,914
R01 · FY2019 · HL
Enhancing the Effectiveness of Varenicline Based Smoking Cessation Treatment$1,946,705
R01 · FY2018 · HL · contact PI
E-Cigarette Effects ON Markers of Cardiovascular AND Pulmonary Disease Risk$458,998
R01 · FY2018 · HL
Testing Relapse Recovery Intervention Components$89,014
P01 · FY2018 · CA · contact PI
Enhancing the Effectiveness of Varenicline Based Smoking Cessation Treatment$1,734,445
R01 · FY2017 · HL · contact PI
Testing Relapse Recovery Intervention Components$89,014
P01 · FY2017 · CA · contact PI
Testing Relapse Recovery Intervention Components$89,014
P01 · FY2016 · CA · contact PI
Testing Relapse Recovery Intervention Components$89,014
P01 · FY2015 · CA · contact PI
Testing Relapse Recovery Intervention Components$89,958
P01 · FY2014 · CA · contact PI
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$1,367,689
P50 · FY2013 · CA
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$864,033
P50 · FY2013 · CA
Identifying Optimal, Translatable Tobacco Cessation Interention Components$382,135
P50 · FY2013 · CA · contact PI
Intervention Optimization Core$185,586
P50 · FY2013 · CA
Intervention Optimization Core$123,434
P50 · FY2013 · CA
Identifying Optimal, Translatable Tobacco Cessation Interention Components$123,433
P50 · FY2013 · CA · contact PI
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$1,697,298
P50 · FY2012 · CA
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$924,233
P50 · FY2012 · CA
Effectiveness of the Chess E-Health Cancer Support Intervention in Population-Bas$449,447
P50 · FY2012 · CA · contact PI
Identifying Optimal, Translatable Tobacco Cessation Interention Components$439,454
P50 · FY2012 · CA · contact PI
Intervention Optimization Core$179,254
P50 · FY2012 · CA
Training in Translational Tobacco Science$170,073
K05 · FY2012 · CA · contact PI
Intervention Optimization Core$132,034
P50 · FY2012 · CA
Identifying Optimal, Translatable Tobacco Cessation Interention Components$132,033
P50 · FY2012 · CA · contact PI
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$1,717,985
P50 · FY2011 · CA
Effectiveness of the Chess E-Health Cancer Support Intervention in Population-Bas$509,363
P50 · FY2011 · CA · contact PI
Identifying Optimal, Translatable Tobacco Cessation Interention Components$430,559
P50 · FY2011 · CA · contact PI
Intervention Optimization Core$178,594
P50 · FY2011 · CA
Training in Translational Tobacco Science$170,073
K05 · FY2011 · CA · contact PI
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$1,872,169
P50 · FY2010 · CA
Effectiveness of the Chess E-Health Cancer Support Intervention in Population-Bas$586,940
P50 · FY2010 · CA · contact PI
Identifying Optimal, Translatable Tobacco Cessation Interention Components$512,726
P50 · FY2010 · CA · contact PI
Intervention Optimization Core$217,411
P50 · FY2010 · CA
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$201,985
P50 · FY2010 · CA
Training in Translational Tobacco Science$170,073
K05 · FY2010 · CA · contact PI
Engineering Effective Interventions for Tobacco Use: A Translational Laboratory$1,862,768
P50 · FY2009 · CA
Effectiveness of the Chess E-Health Cancer Support Intervention in Population-Bas$510,250
P50 · FY2009 · CA · contact PI
Identifying Optimal, Translatable Tobacco Cessation Interention Components$465,555
P50 · FY2009 · CA · contact PI
Intervention Optimization Core$205,372
P50 · FY2009 · CA
Training in Translational Tobacco Science$170,073
K05 · FY2009 · CA · contact PI
Tobacco Dependence: Treatment and Outcomes$1,692,162
P50 · FY2008 · DA · contact PI
Effectiveness of the Chess E-Health Cancer Support Intervention in Population-Bas$424,755
P50 · FY2008 · CA · contact PI
Training in Translational Tobacco Science$170,073
K05 · FY2008 · CA · contact PI
Pharmacotherapies: Efficacy, Mechanisms, and Algorithms$153,886
P50 · FY2008 · DA · contact PI
Tobacco Dependence: Treatment and Outcomes$1,690,549
P50 · FY2007 · DA · contact PI
Pharmacotherapies: Efficacy, Mechanisms, and Algorithms$138,480
P50 · FY2007 · DA · contact PI
Tobacco Dependence: Treatment and Outcomes$1,695,446
P50 · FY2006 · DA · contact PI
Tobacco Dependence: Treatment and Outcomes$130,471
P50 · FY2006 · DA · contact PI
Pharmacotherapies: Efficacy, Mechanisms, and Algorithms$120,943
P50 · FY2006 · DA · contact PI
Tobacco Dependence: Treatment and Outcomes$1,734,408
P50 · FY2005 · DA
Pharmacotherapies: Efficacy, Mechanisms, and Algorithms$534,081
P50 · FY2005 · DA
Tobacco Dependence: Treatment and Outcomes$46,595
P50 · FY2005 · DA
Tobacco Dependence: Treatment and Outcomes$1,645,747
P50 · FY2004 · DA
Pharmacotherapies: Efficacy, Mechanisms, and Algorithms$542,917
P50 · FY2004 · DA
Component and Couple Analysis of Cancer Communications$0
P50 · FY2003 · CA
Negative affect in relapse: Withdrawal and treatment medication$0
P50 · FY2002 · CA
Negative affect in relapse: Withdrawal and treatment medication$0
P50 · FY2002 · CA
Negative affect in relapse: Withdrawal and treatment medication$0
P50 · FY2001 · CA
Negative affect in relapse: Withdrawal and treatment medication$0
P50 · FY2001 · CA
Negative affect in relapse: Withdrawal and treatment medication$474,021
P50 · FY2000 · CA